Tasquinimod (ABR-215050), a quinoline-3-carboxamide anti-angiogenic agent, modulates the expression of thrombospondin-1 in human prostate tumors

Overview of attention for article published in Molecular Cancer, May 2010

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 Wikipedia article.

In April 2011, Ipsen and Active Biotech entered into a broad partnership for the co-development of tasquinimod for the treatment of cancer.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.